Yoga for Treatment of Overactive Bladder in Pediatric Patients

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this pilot study is to assess the impact of yoga as a treatment modality in pediatric patients age 8-18 diagnosed with idiopathic overactive bladder as measured by validated questionnaires and urinary biomarkers. The main question it aims to answer is: Does yoga help improve overactive bladder symptoms in this patient population? Participants will take part in a weekly yoga session for a total of 6 weeks with validated questionnaires and urinary samples for biomarkers to be completed at the beginning, middle and end of the study. This study will follow a cross-over study design and patients will receive standard of care while not in the active treatment arm.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 8
Maximum Age: 18
Healthy Volunteers: f
View:

• 8-18 years of age

• History of non-neurogenic overactive bladder or detrusor overactivity and/or urinary incontinence (ICD 10 codes respectively - N32.81, N39.498)

• Obtained legally effective informed consent and Health Insurance Portability and Accountability Act (HIPPA) authorization from the participant or the participant's parent/legal guardian

• Minor participant is willing and able to provide assent (as applicable)

• Vancouver Dysfunctional Elimination Syndrome\[15\] score of ≥11 and a positive modified bother score within 30 days of consent

Locations
United States
North Carolina
Duke University Hospital
RECRUITING
Durham
Contact Information
Primary
Rafael Tua-Caraccia, MD
rdt25@duke.edu
7865546150
Backup
Jonathan Routh, MD, MPH
jonathan.routh@duke.edu
(919) 684-6994
Time Frame
Start Date: 2025-06
Estimated Completion Date: 2025-09
Participants
Target number of participants: 40
Treatments
Experimental: 1.1: 8-12 yoga first
Experimental: 1.2: 13-18 yoga first
Experimental: 2.1: 8-12 yoga second
Experimental: 2.2: 13-18 yoga second
Related Therapeutic Areas
Sponsors
Leads: Duke University

This content was sourced from clinicaltrials.gov